Showing all 6 results
Pharma Leader Series: Top 26 Asthma & COPD Companies 2020-2030
The global asthma & COPD therapies market was valued at $36.21bn in 2018 and is projected to grow to $60.8bn...
Full DetailsPUBLISHED: 17 February 2020The Global Respiratory Inhalers Market 2020-2030
Visiongain estimates that the global respiratory inhalers market reached $32.6bn in 2019 and will grow at a CAGR of 3.9%...
Full DetailsPUBLISHED: 28 January 2020Pharma Leader Series: Top 55 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2020
Contract manufacturing represents the largest sector of the pharma outsourcing industry. Pharmaceutical companies have sought to take advantage of the...
Full DetailsPUBLISHED: 16 January 2020Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market Forecast to 2029
The global anti-idiopathic pulmonary fibrosis drugs market is expected to grow at a CAGR of 16.7% in the first half...
Full DetailsPUBLISHED: 26 November 2019Top 20 Global Respiratory Inhalers Manufacturers 2019
The global respiratory inhalers market is estimated to reach $38bn in 2023. In the respiratory Inhalers market the top three...
Full DetailsPUBLISHED: 09 April 2019Global Asthma & COPD Therapies Market 2019-2029
The global asthma & COPD therapies market was valued at $32bn in 2018 and is projected to grow at a...
Full DetailsPUBLISHED: 19 March 2019
